British regulator 30 rare blood clots found in people vaccinated with AstraZeneca in the UK, But they emphasized the benefits of this preparation against covid-19.
The Medicines and Health Care Regulatory Agency (MHRA) insisted today that The risk associated with these blood clots is “very small” And when a vaccine is provided, the public should accept the vaccine.
These situations Vaccination in 18.1 million people in the UK Until the end of March.
Among these 30 incidents, 22 corresponds to venous cerebral thrombosis (CVST) and Eight other problems related to blood clotting Low platelets.
Adam Finn, a member of the Joint Committee on Vaccines and Immunization (JCVI) in charge of the country’s vaccination program, pointed out that the current preparations are ” The safest option to reduce the risk of serious illness Or die of covid-19″.
Finn of Bristol English University told the media on Friday that these cases are “Study very carefully to better understand” Is there some kind of “vaccination opportunity”.
“despite this, Extremely rare With millions of doses already vaccinated, many of these cases mean that the decision to determine the risks or benefits people face when they are invited to receive the covid-19 vaccine is simple: Of course, accept it in the following way Vaccines are the safest option. “
Regulatory agency has designated Have not yet received notification of blood clot problems for people who have been vaccinated From BioNTech / Pfizer.
The information will be exposed later Germany decides to suspend the use of AstraZeneca for people under 60 Worry may be related to blood clots.
At the same time, the European Medicines Agency (EMA) has stated, “No evidence “restricted use The proportion of AstraZeneca vaccines in the population.
In addition to this preparation, the United Kingdom is also vaccinating Pfizer there are more 30 million people At least the first of the two vaccines has been received.